Profile
David Groberman was the founder of HeraMED Ltd.
where he served as the Chief Executive Officer & Executive Director from 2018 to 2023.
He was also the founder of Meytar R&D where he served as the Chief Technology Officer.
HeraMED Ltd.
was founded in 2011 and Meytar R&D was founded in 2005.
Mr. Groberman received his undergraduate degree from Tel-Aviv University in 2000.
Mr. Groberman is also the founder of Breath.
Me Ltd.
Former positions of David Groberman
| Companies | Position | End |
|---|---|---|
| HERAMED LIMITED | Founder | 2023-11-07 |
Breath.Me Ltd.
 Breath.Me Ltd. Medical SpecialtiesHealth Technology Breath.Me Ltd. has developed the world's first affordable smart spirometry device that is entirely mechanical and can be attached to a smartphone. The company is based in Raanana, Israel, and was founded by Tal Slonim, David Groberman, and Rahav Cohen, who has been the CEO since incorporation. The innovative device converts exhaled air into an acoustic signal, and a proprietary algorithm extracts spirometric values. The Israeli company offers a disease management platform for both patients and care providers, providing meaningful insights through data analysis that enables smart prediction for better management and prevention. The device incorporates environmental data such as weather, pollution, and pollen to provide personal insights tailored for each individual. | Founder | - |
| Meytar R&D | Founder | - |
Training of David Groberman
| Tel-Aviv University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| HERAMED LIMITED | Technology Services |
| Private companies | 2 |
|---|---|
| Meytar R&D | |
Breath.Me Ltd.
Breath.Me Ltd. Medical SpecialtiesHealth Technology Breath.Me Ltd. has developed the world's first affordable smart spirometry device that is entirely mechanical and can be attached to a smartphone. The company is based in Raanana, Israel, and was founded by Tal Slonim, David Groberman, and Rahav Cohen, who has been the CEO since incorporation. The innovative device converts exhaled air into an acoustic signal, and a proprietary algorithm extracts spirometric values. The Israeli company offers a disease management platform for both patients and care providers, providing meaningful insights through data analysis that enables smart prediction for better management and prevention. The device incorporates environmental data such as weather, pollution, and pollen to provide personal insights tailored for each individual. | Health Technology |
- Stock Market
- Insiders
- David Groberman